We are live on ! Find out more
BRM

Boston Research & Management Portfolio holdings

AUM $421M
1-Year Est. Return 16.18%
This Fund
S&P 500
This Quarter Est. Return
+7.29%
1 Year Est. Return
+16.18%
3 Year Est. Return
+48.21%
5 Year Est. Return
+65.09%
10 Year Est. Return
+242.1%
AUM
$199M
AUM Growth
+$3.73M
Cap. Flow
-$8.84M
Cap. Flow %
-4.43%
Top 10 Hldgs %
24.27%
Holding
98
New
2
Increased
5
Reduced
64
Closed
1

Sector Composition

Rank Sector Weight
1 Industrials 14.54%
2 Technology 13.69%
3 Financials 12.39%
4 Healthcare 11.03%
5 Consumer Staples 10.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$180B
$3.34M 1.67%
58,502
-2,705
-4% -$150K
CMCSA icon
27
Comcast
CMCSA
$79.1B
$3.32M 1.66%
82,835
-2,160
-3% -$81.2K
GOOGL icon
28
Alphabet (Google) Class A
GOOGL
$3.91T
$3.29M 1.65%
62,500
-2,100
-3% -$108K
WFC icon
29
Wells Fargo
WFC
$261B
$3.28M 1.64%
54,029
-2,550
-5% -$144K
STT icon
30
State Street
STT
$50.9B
$3.23M 1.62%
33,151
-830
-2% -$79.3K
TSCO icon
31
Tractor Supply
TSCO
$16.3B
$3.21M 1.61%
214,750
-6,200
-3% -$79.6K
IEFA icon
32
iShares Core MSCI EAFE ETF
IEFA
$186B
$3.13M 1.57%
47,432
-873
-2% -$56.9K
MDT icon
33
Medtronic
MDT
$107B
$3.12M 1.57%
38,656
-405
-1% -$32.4K
COP icon
34
ConocoPhillips
COP
$147B
$3.08M 1.55%
56,151
-890
-2% -$45.8K
BNY
35
Bank of New York Mellon
BNY
$108B
$3.07M 1.54%
57,005
-1,865
-3% -$99.3K
PG icon
36
Procter & Gamble
PG
$343B
$3.02M 1.51%
32,847
-560
-2% -$50.4K
WU icon
37
Western Union
WU
$2.57B
$2.73M 1.37%
143,735
-5,240
-4% -$103K
CVS icon
38
CVS Health
CVS
$137B
$2.66M 1.34%
36,745
-4,847
-12% -$352K
PX
39
DELISTED
Praxair Inc
PX
$2.65M 1.33%
17,145
-475
-3% -$70.5K
SPY icon
40
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$2.61M 1.31%
9,791
-700
-7% -$182K
VZ icon
41
Verizon
VZ
$194B
$2.56M 1.28%
48,414
+1,900
+4% +$93.4K
OMC icon
42
Omnicom Group
OMC
$22.7B
$2.53M 1.27%
34,799
-1,760
-5% -$126K
USB icon
43
US Bancorp
USB
$99.6B
$2.4M 1.2%
44,705
+35
+0.1% +$1.88K
BBH icon
44
VanEck Biotech ETF
BBH
$396M
$2.13M 1.07%
17,113
-4,875
-22% -$623K
GE icon
45
GE Aerospace
GE
$367B
$2.09M 1.05%
24,988
-6,006
-19% -$573K
HYG icon
46
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$1.94M 0.97%
22,230
-930
-4% -$81.6K
VB icon
47
Vanguard Small-Cap ETF
VB
$79.5B
$1.88M 0.94%
12,750
-1,010
-7% -$146K
HD icon
48
Home Depot
HD
$332B
$1.86M 0.93%
9,795
-880
-8% -$152K
VTI icon
49
Vanguard Total Stock Market ETF
VTI
$654B
$1.7M 0.85%
12,380
MOS icon
50
The Mosaic Company
MOS
$7.09B
$1.61M 0.81%
62,850
-6,890
-10% -$158K

Similar funds

Boston Research & Management's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Research & Management held 98 positions worth $199M, up 1.9% from $196M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Boston Research & Management withdrew a net $8.84M in Q4 2017, closing 1 position and reducing 64 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $433K position sold in full.

By sector, the portfolio is most concentrated in Industrials at 15% of assets, down from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Boston Research & Management opened a new position in iShares Biotechnology ETF worth $529K.

  • Boston Research & Management's largest Q4 2017 buy was iShares Biotechnology ETF: 4,959 shares worth $529K.
  • Boston Research & Management added most to iShares Core S&P 500 ETF in Q4 2017, an estimated $582K increase.
  • Boston Research & Management's biggest Q4 2017 reduction was VanEck Biotech ETF, cutting an estimated $623K.
  • Boston Research & Management fully exited State Street Energy Select Sector SPDR ETF in Q4 2017, selling an estimated $433K.
  • Boston Research & Management's ten largest holdings make up 24% of its $199M portfolio in Q4 2017.
  • Boston Research & Management opened 2 new positions and closed 1 in Q4 2017.
  • Boston Research & Management's portfolio value rose 1.9% quarter-over-quarter to $199M.

Based on Boston Research & Management's 13F filing for Q4 2017, filed 9 Feb 2018.